Nrxn2 | neurexin II
Physiological systems
19 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Homeostasis/metabolism Growth/size/body region Behavior/neurological Cardiovascular system
15 No significant impact
5 Not tested
Data collections
Gene metrics:11Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| abnormal gait | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Early adult | 4.31x10-5 | ||
| hyperactivity | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Late adult | 6.83x10-6 | ||
| trunk curl | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Early adult | 6.64x10-6 | ||
| enlarged heart | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Late adult | N/A * | ||
| increased blood urea nitrogen level | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Early adult | 2.34x10-12 | ||
| increased lean body mass | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Late adult | 6.91x10-5 | ||
| decreased locomotor activity | 4 supporting datasets | Nrxn2em1(IMPC)H | homozygote | Early adult | 2.6x10-5 | ||
| tremors | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Late adult | 4.76x10-5 | ||
| increased circulating cholesterol level | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Early adult | 1.29x10-8 | ||
| increased circulating total protein level | 1 supporting dataset | Nrxn2em1(IMPC)H | homozygote | Early adult | 3.74x10-7 |
| | | | | | | | | | |
External links
No external links available for Nrxn2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Nrxn2em1(IMPC)H | Exon Deletion | | mouse |